BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13761775)

  • 1. An investigation of the carrier state in the Duchenne type muscular dystrophy.
    LEYBURN P; THOMSON WH; WALTON JN
    Ann Hum Genet; 1961 May; 25():41-9. PubMed ID: 13761775
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive sex-linked juvennile (Duchenne) type by serum creatine-phosphokinase determinations.
    AEBI U; RICHTERICH R; COLOMBO JP; ROSSI E
    Epilepsia; 1961-1962; 1():61-74. PubMed ID: 13859504
    [No Abstract]   [Full Text] [Related]  

  • 3. The carrier state in muscular dystrophy of the Duchenne type.
    Milhorat AT; Goldstone L
    JAMA; 1965 Oct; 194(2):130-4. PubMed ID: 5897511
    [No Abstract]   [Full Text] [Related]  

  • 4. Duchenne muscular dystrophy manifesting carriers.
    Boylan K
    Arch Neurol; 1990 Sep; 47(9):951-2. PubMed ID: 2396934
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of carrier states in progressive muscular dystrophy of the Duchenne X-recessive type. Correlative pluridimensional investigations].
    Radu H; Roşu AM; Killyen I; Ionescu V
    Pediatria (Bucur); 1973; 22(2):97-110. PubMed ID: 4720589
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection.
    Gardner-Medwin D
    J Neurol Neurosurg Psychiatry; 1968 Apr; 31(2):124-34. PubMed ID: 5684019
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities of the electrocardiogram in female carriers of Duchenne muscular dystrophy.
    Emery AE
    Br Med J; 1969 May; 2(5654):418-20. PubMed ID: 5781488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne muscular dystrophy manifesting carriers.
    Barkhaus PE; Gilchrist JM
    Arch Neurol; 1989 Jun; 46(6):673-5. PubMed ID: 2730379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of Duchenne and Becker's muscular dystrophy: clinical applications.
    Gutmann DH; Fischbeck KH
    Ann Neurol; 1989 Aug; 26(2):189-94. PubMed ID: 2673003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The muscular dystrophies.
    Bushby KM
    Baillieres Clin Neurol; 1994 Aug; 3(2):407-30. PubMed ID: 7952855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abortion programme in Duchenne muscular dystrophy in Japan.
    Kondo K; Tsubaki T
    Lancet; 1973 Mar; 1(7802):543. PubMed ID: 4119965
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ceruloplasmin in patients with Duchenne muscular dystrophy].
    Reyes J; Holmgren J; Colombo M
    Rev Med Chil; 1991 Mar; 119(3):258-61. PubMed ID: 1842117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular dystrophies and other genetic myopathies.
    Shieh PB
    Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the Duchenne muscular dystrophy gene.
    Prior TW
    Arch Pathol Lab Med; 1991 Oct; 115(10):984-90. PubMed ID: 1898245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A manifested carrier of late onset Duchenne type muscular dystrophy].
    Wakata N; Uchida A; Kinoshita M
    Rinsho Shinkeigaku; 1987 May; 27(5):630-3. PubMed ID: 3621760
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible manifestation of the dystrophic X chromosome in muscle cultures from carriers of Duchenne muscular dystrophy.
    Thompson EJ; Yasin R; Lake BD; Cavanagh NP
    Exp Neurol; 1983 Mar; 79(3):720-8. PubMed ID: 6825761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of gene deletion in patients of Duchenne muscular dystrophy/Becker muscular dystrophy using polymerase chain reaction.
    Sinha S; Pradhan S; Mittal RD; Mittal B
    Indian J Med Res; 1992 Oct; 96():297-301. PubMed ID: 1459673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 19. SERUM ENZYME VARIATIONS AND HISTOLOGICAL ABNORMALITIES IN THE CARRIER STATE IN DUCHENNE DYSTROPHY.
    STEPHENS J; LEWIN E
    J Neurol Neurosurg Psychiatry; 1965 Apr; 28(2):104-8. PubMed ID: 14285647
    [No Abstract]   [Full Text] [Related]  

  • 20. The Duchenne type muscular dystrophy: histopathological studies of the carrier state.
    Pearce GW; Pearce JM; Walton JN
    Brain; 1966 Mar; 89(1):109-20. PubMed ID: 5910897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.